Search - tctmd.com

Displaying 1 - 20 of 162

Sort: Relevancy | Date

Multiple Arterial CABG Benefits Both Sexes, but Risk Cutoffs Vary

News Daily News

Multiple Arterial CABG Benefits Both Sexes, but Risk Cutoffs Vary

Yael L. Maxwell

December 24, 2020

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

December 18, 2020

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

December 14, 2020

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

Machine Learning Based on ECG, Clinical Data Predicts Coronary Calcium

News Daily News

Machine Learning Based on ECG, Clinical Data Predicts Coronary Calcium

December 04, 2020

As Paclitaxelgate Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

News Conference News VIVA 2020

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

November 27, 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

News Conference News PCR London Valves 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Michael O'Riordan

November 25, 2020

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

November 19, 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

November 17, 2020

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

News Conference News AHA 2020

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

November 17, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

FIDELIO-DKD: Finerenone Cuts CV Events in Diabetic Kidney Disease

News Conference News AHA 2020

FIDELIO-DKD: Finerenone Cuts CV Events in Diabetic Kidney Disease

November 16, 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

News Conference News AHA 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

November 16, 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

November 15, 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

November 14, 2020

OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

News Conference News AHA 2020

OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

November 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.